Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier

Kidney International

Volumn 67, Issue 1, 2005, Pages 152-156

  McCarthy, Ellen T ^a   Sharma, Ram ^b   Sharma, Mukut ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

20 HETE; Cytochrome P450; Glomerular protein permeability; Puromycin

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ALBUMIN; CLOFIBRATE; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; GLOMERULUS EPITHELIUM; ICOSANOID METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 10944228342     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00065.x     Document Type: Article

References (43)

1. SCHNAPER HW, ROBSON AM: Nephrotic syndrome: Minimal change disease, focal glomerulosclerosis, and related disorders, in Diseases of the Kidney (vol 2), edited by Schrier RW, Gottschalk CW, Boston, Little, Brown and Company, 1993, pp 1731-1784
2. CUMMINGS BS, LASKER JM, LASH LH: Expression of glutathione-dependent enzymes and cytochrome P450s in freshly isolated and primary cultures of proximal tubular cells from human kidney. J Pharm Exp Ther 293:677-685, 2000
3. LIN F, ABRAHAM NG, SCHWARTZMAN ML: Cytochrome P450 arachidonic acid ω-hydroxylation in the proximal tubule of the rat kidney. Ann NY Acad Sci 744:11-24, 1994
4. YOSHIMURA R, YOSHIMURA N, OHYAMA A, et al: The effect of immunosuppressive agents (FK-506, rapamycin) on renal P450 systems in rat models. J Pharm Pharmacol 51:941-948, 1999
5. NAKAMURA M, IMAOKA S, MIURA K, et al: Y. Induction of cytochrome P450 isozymes in rat renal microsomes by cyclosporine A. Biochem Pharmacol 48:1743-1746, 1994
6. ITO O, OMATA K, ITO S, et al: Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid. Am J Physiol 280:R822-R830, 2001
7. SHARMA RK, LAKE BG, MAKOWSKI R, et al: Differential induction of peroxisomal and microsomal fatty-acid oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterization of a renal cytochrome P-450 and implications for peroxisome proliferation. Eur J Biochem 184:69-78, 1989
8. ALONSO-GALICIA M, FROHLICH B, ROMAN RJ: Induction of P4504 A activity improves pressure-natriuresis in Dahl S rats. Hypertension 31:232-236, 1998
9. CUMMINGS BS, ZANGAR RC, NOVAK RF, LASH LH: Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metab Disp 27:542-548, 1999
10. ROMAN RJ, MA YH, FROUHLICH B, MARKHAM B: Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. Hypertension 26:985-988, 1993
11. ITO O, ROMAN RJ: Regulation of P-450 4A activity in the glomerulus of the rat. Am J Physiol 276:R1749-R1757, 1999
12. MCGIFF JC, QUILLEY J: 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol 277:R607-R623, 1999
13. ROMAN RJ, MAIER KG, SUN CW, et al: Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27:855-865, 2000
14. FOGO AB: Animal models of FSGS: Lessons for pathogenesis and treatment. Semin Nephrol 23:161-171, 2003
15. SAVIN VJ, SHARMA R, LOVELL HB, WELLING DJ: Measurement of albumin reflection coefficient using isolated rat glomeruli. J Am Soc Nephrol 3:1260-1269, 1992
16. KRISHNAMURTI U, ZHOU B, FIN WW, et al: Puromycin aminonucleoside suppresses integrin expression in cultured glomerular epithelial cells. J Am Soc Nephrol 12:758-766, 2001
17. LIU H, SHAH SV, BALIGA R: Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats. Am J Physiol 280:F88-F94, 2001
18. LIU H, BALIGA M, BIGLER SA, BALIGA R: Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity of glomerular epithelial cells. Nephron Exp Nephrol 94:e17-e24, 2003
19. ZOU AP, FLEMING JT, FALCK JR, et al: 20-HETE is an endogenous inhibitor of the large-conductance Ca(+2)-activated K+ channel in renal arterioles. Am J Physiol 270:R228-R237, 1996
20. IMIG JD, ZOU AP, STEC DE, et al: Formation and actions of 20-hydroxyeicosatetraenoic acid in rat arterioles. Am J Physiol 270:R217-R227, 1996
21. SUN CW, FALCK JR, HARDER DR, ROMAN RJ: Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33:414-418, 1999
22. FISHMAN JA, KARNOVSKY MJ: Effects of the aminonucleoside puromycin on glomerular epithelial cells in vitro. Am J Pathol 118:398-407, 1985
23. LANNIGAN R, KARK R, POLLAK VE: The effect of a single intravenous injection of aminonucleoside puromycin on the rat kidney: A light- and electron-microscope study. J Pathol Bact 83:357-362, 1962
24. GWINNER W, LANDMESSER U, BRANDES RP, et al: Reactive oxygen species and antioxidant defense in puromycin aminonucleoside glomerulopathy. J Am Soc Nephrol 8:1722-1731, 1997
25. AOYAGI K, AKIYAMA K, TOMIDA C, et al: Imaging of hydroperoxides in a rat glomerulus stimulated by puromycin aminonucleoside. Kidney Int 55:s153-s155, 1999
26. KAWACHI H, KOIKE H, KURIHARA H, et al: Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57:1949-1961, 2000
27. MCCARTHY ET, SHARMA M: Indomethacin protects permeability barrier from focal segmental glomerulosclerosis serum. Kidney Int 61:534-541, 2002
28. ITO O, ALONSO-GALICIA M, HOPP K, ROMAN RJ: Localization of cytochrome P-450 4A isoforms along the rat nephron segments. Am J Physiol 274:F395-F404, 1998
29. IMAOKA S, OGAWA H, KIMURA S, GONZALEZ FJ: Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid co-hydoxylase expressed in human kidney. DNA Cell Biol 12:893-899, 1993
30. SCHWARTZMAN ML, MARTASEK P, RIOS AR, et al: Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 37:94-99, 1990
31. MA YH, SCHWARTZMAN ML, ROMAN RJ: Altered renal P450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol 267:R579-R589, 1994
32. HATTORI T, NAGAMAATSU T, ITO M, SUZUKI Y: The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats. Jpn J Pharmacol 70:25-33, 1996
33. KOKUI K, YOSHIKAWA N, NAKAMURA H, et al: Cyclosporine reduces proteinuria in rats with aminonucleoside nephrosis. J Pathol 166:297-301, 1992
34. KAWAMURA T, YOSHIMASA T, BILLS T, et al: Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291-301, 1991
35. TANAKA R, KON V, YOSHIOKA T, et al: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 45:537-543, 1994
36. HOAGLAND KM, MAIER KG, ROMAN RJ: Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl Salt-sensitive rats. Hypertension 41:697-702, 2003
37. 2α. J Lipid Res 31:1477-1482, 1990
38. KALSOTRA A, ANAKK S, BOEHME CL, STROBEL HW: Sexual dimorphism and tissue specificity in the expression of CYP4F forros in Sprague Dawley rats. Drug Metab Disp 30:1022-1028, 2002
39. BARISONI L, KOPP JB: Update in podocyte biology: Putting one's best foot forward. Curr Opin Nephrol Hypertens 12:251-259, 2003
40. RANDRIAMBOAVONIY V, BUSSE R, FLEMING I: 20-HETE-induced contraction of small coronary arteries depends on the activation of rho-kinase. Hypertension 41:801-806, 2003
41. MCCARTHY ET, SHARMA R, SHARMA M, et al: TNF-alpha increases albumin permeability of isolated rat glomeruli through the generation of superoxide. J Am Soc Nephrol 9:433-438, 1998
42. SHARMA R, SHARMA M, KHANNA AK, SAVIN VJ: Transforming growth factor increases glomerular albumin permeability via hydroxyl radicals. Kidney Int 58:131-136, 2000
43. SHARMA M, SHARMA R, MCCARTHY ET, SAVIN VJ: The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects, Exp Biol Med 229:85-98, 2004